Open original FDA record ↗Recall record
- FDA identifier
- Z-2025-2010
- Company in FDA record
- Becton Dickinson & Co.
- FDA classification date
- Jul 15, 2010
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
In vitro diagnostic reagent to aid in the diagnosis of Salmonellosis may exhibit decreased or no reactivity. If proper controls are run with the lot in question, it would become apparent that the antigen is non reactive and patient specimen results should not be reported. If control testing is not performed a salmonella-infected patient could go undiagnosed, with possible adverse effects.
Source facts
- Action
- The recalling firm notified customers by fax and e-mail on 05/19/10. The notification advised that the referenced lot number of Salmonella 0 Group A Antigen may exhibit decreased or no reactivity when testing the patient's serum directly for homologous antibodies by either a slide or tube agglutination test to aid in the diagnosis of Salmonellosis. The recalling firm also advised that they would issue replacements for the referenced lot number under Catalog number 240731, which would not be available until approximately July 15, 2010. Consignees were requested to return enclosed response form. Customers with questions about replacements should contact BD customer service at 1-800-675-0908. For all other inquiries, please contact BD Technical Services Department at 1-800-638-8663.
- Initiated
- 2010-05-19
- Root cause
- Nonconforming Material/Component
- Terminated
- 2010-07-21
- Distribution
- Product was sold to distributors nationwide and to affiliates in Belgium and Korea.
- Recall number
- Z-2025-2010
- Recall status
- Terminated
- CDRH record ID
- 92092
- FDA classified
- 2010-07-15
- Recall event number
- 55867